ANTI-IRAK ANTIBODY

Specificity

Recognizes IRAK.

Immunogen

Peptide (DRQGPEESDEFQS) corresponding to amino acids 700-712 of human IRAK

Application

Detect IRAK using this Anti-IRAK Antibody validated for use in IP & WB.

Research Category
Signaling

Research Sub Category
Immunological Signaling

Quality

routinely evaluated by immunoblot on HeLa nuclear extract

Target description

80 kDa

Physical form

Ammonium sulfate precipitation and DEAE-cellulose chromatography

Format: Purified

Protein A Purified immunoglobulin in 30% glycerol, 0.07M Tris-glycine, pH 7.4, 0.105 M NaCl, 0.035% sodium azide as a preservative.

Storage and Stability

Maintain for 2 years at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Analysis Note

Control
Positive Antigen Control: Catalog #12-309, Hela cell nuclear extract. Add an equal volume of Laemmli reducing sample buffer to 10 μL of extract and boil for 5 minutes to reduce the preparation. Load 20 μg of reduced extract per lane for minigels.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.